XXII
22nd Century GroupXXII
XXII
About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Employees: 64
0
Funds holding %
of 7,363 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
5.62% less ownership
Funds ownership: 15.96% [Q3] → 10.34% (-5.62%) [Q4]
18% less funds holding
Funds holding: 38 [Q3] → 31 (-7) [Q4]
60% less capital invested
Capital invested by funds: $739K [Q3] → $299K (-$440K) [Q4]
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
76% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 17
Research analyst outlook
We haven’t received any recent analyst ratings for XXII.
Financial journalist opinion
Neutral
GlobeNewsWire
1 day ago
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly
Smoker Friendly Adds Both VLN and Smoker Friendly Branded VLN Reduced Nicotine Content Products to its Store Lineup MOCKSVILLE, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced that it has signed an agreement with Smoker Friendly, one of its largest customers, to launch Smoker Friendly VLN branded reduced nicotine content cigarette products that will become the first VLN partner brand.
Neutral
Newsfile Corp
2 weeks ago
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)
Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed.
Neutral
GlobeNewsWire
1 month ago
22nd Century to Present at the Emerging Growth Conference on February 19, 2025
MOCKSVILLE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present at the Emerging Growth Conference on Wednesday, February 19, 2025, at 10:50 am Eastern Time.
Neutral
GlobeNewsWire
1 month ago
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards
MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2).
Neutral
GlobeNewsWire
1 month ago
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
Neutral
GlobeNewsWire
1 month ago
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers
VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA's War on Smoking
Neutral
GlobeNewsWire
1 month ago
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food and Drug Administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the U.S. Office of Management and Budget on January 3, 2025.
Neutral
GlobeNewsWire
2 months ago
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly
Agreement covers 11 existing brands, supports launch 8 additional premium brands with Smoker Friendly retail and dealer locations
Neutral
Newsfile Corp
2 months ago
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
Neutral
Newsfile Corp
2 months ago
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Recent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden Administration Mocksville, North Carolina--(Newsfile Corp. - December 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it applauds action by the U.S. Food and Drug Administration to advance its long-standing proposal mandating a drastic reduction in the amount of nicotine in cigarettes, a cornerstone goal of public health experts seeking to reduce the harms of smoking. "We are excited to see definitive action by the FDA intended to advance its scientifically backed reduced nicotine content mandate for cigarette products, a non-partisan proposal that actually began moving forward during the first Trump administration and continued its progress during the Biden administration," said Larry Firestone, Chief Executive Officer of 22nd Century Group.
Charts implemented using Lightweight Charts™